196 related articles for article (PubMed ID: 29030633)
1. The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis.
Horita N; Nagashima A; Nakashima K; Shibata Y; Ito K; Goto A; Yamanaka T; Kaneko T
Sci Rep; 2017 Oct; 7(1):13185. PubMed ID: 29030633
[TBL] [Abstract][Full Text] [Related]
2. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
3. Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naïve advanced non-small-cell lung cancer in the era of third-generation agents.
Jiang J; Liang X; Zhou X; Huang R; Chu Z; Zhan Q
J Cancer Res Clin Oncol; 2013 Jan; 139(1):25-38. PubMed ID: 22864816
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis.
Chen H; Horita N; Ito K; Nagakura H; Hara Y; Kobayash N; Yamamoto M; Kudo M; Kaneko T
Ther Adv Med Oncol; 2020; 12():1758835920965841. PubMed ID: 33403010
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.
Le Chevalier T; Scagliotti G; Natale R; Danson S; Rosell R; Stahel R; Thomas P; Rudd RM; Vansteenkiste J; Thatcher N; Manegold C; Pujol JL; van Zandwijk N; Gridelli C; van Meerbeeck JP; Crino L; Brown A; Fitzgerald P; Aristides M; Schiller JH
Lung Cancer; 2005 Jan; 47(1):69-80. PubMed ID: 15603856
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
Kosmas C; Tsavaris N; Vadiaka M; Stavroyianni N; Koutras A; Malamos N; Onyenadum A; Rokana S; Polyzos A; Kalofonos HP
Cancer; 2001 Dec; 92(11):2902-10. PubMed ID: 11753965
[TBL] [Abstract][Full Text] [Related]
7. Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.
Baggstrom MQ; Stinchcombe TE; Fried DB; Poole C; Hensing TA; Socinski MA
J Thorac Oncol; 2007 Sep; 2(9):845-53. PubMed ID: 17805063
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab in combination with different platinum-based doublets in the first-line treatment for advanced nonsquamous non-small-cell lung cancer: A network meta-analysis.
Zhao S; Gao F; Zhang Y; Zhang Z; Zhang L
Int J Cancer; 2018 Apr; 142(8):1676-1688. PubMed ID: 29171009
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non-small-cell Lung Cancer in China.
Li X; Abbas M; Li Y; Teng Y; Fang Y; Yu S; Wen Y; Wang L; Shi M
Clin Ther; 2019 Mar; 41(3):518-529. PubMed ID: 30846285
[TBL] [Abstract][Full Text] [Related]
10. Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.
Pujol JL; Barlesi F; Daurès JP
Lung Cancer; 2006 Mar; 51(3):335-45. PubMed ID: 16478643
[TBL] [Abstract][Full Text] [Related]
11. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
de Castria TB; da Silva EM; Gois AF; Riera R
Cochrane Database Syst Rev; 2013 Aug; (8):CD009256. PubMed ID: 23949842
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-containing regimens vs others in first-line treatment of NSCLC.
Natale RB
Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):27-31. PubMed ID: 15339056
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib.
White MN; Piper-Vallillo AJ; Gardner RM; Cunanan K; Neal JW; Das M; Padda SK; Ramchandran K; Chen TT; Sequist LV; Piotrowska Z; Wakelee HA
Clin Lung Cancer; 2022 May; 23(3):e210-e221. PubMed ID: 34887193
[TBL] [Abstract][Full Text] [Related]
15. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.
Kubota K; Kawahara M; Ogawara M; Nishiwaki Y; Komuta K; Minato K; Fujita Y; Teramukai S; Fukushima M; Furuse K;
Lancet Oncol; 2008 Dec; 9(12):1135-42. PubMed ID: 19013107
[TBL] [Abstract][Full Text] [Related]
16. Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer.
Pimentel FL; Bhalla S; Laranjeira L; Guerreiro M
Lung Cancer; 2006 Jun; 52(3):365-71. PubMed ID: 16650499
[TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness analysis comparing carboplatin and weekly paclitaxel with cisplatin and docetaxel in the treatment of advanced non-small cell lung carcinoma].
Inage S; Ise Y; Obayashi M; Katayama S; Gemma A
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2093-100. PubMed ID: 21084806
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.
Zhu J; Sharma DB; Chen AB; Johnson BE; Weeks JC; Schrag D
Cancer; 2013 Jun; 119(11):2048-60. PubMed ID: 23564469
[TBL] [Abstract][Full Text] [Related]
19. Comparing first-line treatment patterns and clinical outcomes of patients with pan-negative advanced non-squamous non-small cell lung cancer.
Xu H; Xu F; Zhu W; Ying J; Wang Y
Thorac Cancer; 2018 Aug; 9(8):1005-1011. PubMed ID: 29917332
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer.
Gao G; Jiang J; Liang X; Zhou X; Huang R; Chu Z; Zhan Q
Lung Cancer; 2009 Sep; 65(3):339-44. PubMed ID: 19144444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]